Outcomes and Mortality in Renal Transplant Recipients Admitted to the Intensive Care Unit

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Citação
TRANSPLANTATION PROCEEDINGS, v.47, n.9, p.2694-2699, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction. In the intensive care unit (ICU), mortality is considered higher among renal transplant recipients than among nontransplantation patients. However, data regarding severe complications after kidney transplantation are scarce. Materials and Methods. In this study, we evaluated all consecutive renal transplant recipients admitted to our ICU between July 2012 and July 2013 (n = 70), comparing their outcomes with those of a control group of nontransplantation patients admitted during the same period (n = 153). Among the transplant recipients, we compared survivors and nonsurvivors to identify predictors of ICU mortality. Results. The mean age of the transplant recipients was 52 13 years. Of the 70 transplant recipients, 18 (25%) required mechanical ventilation, 28 (40%) required inotropic support, and 27 (39%) required hemodialysis, all of which are factors that worsen the prognosis significantly. Twenty-two (31%) of the transplant recipients died in the ICU and 17 (24%) died within 30 days after ICU discharge, rates similar to those observed for the control group. Conclusions. We observed similar mortality between recipient and control groups, albeit the mortality was higher in the clinical group. In the multivariate model, the need for mechanical ventilation and the need for hemodialysis were independently associated with mortality.
Palavras-chave
Referências
  1. El-Zoghby ZM, 2009, AM J TRANSPLANT, V9, P527, DOI 10.1111/j.1600-6143.2008.02519.x
  2. Mouloudi E, 2012, TRANSPL P, V44, P2718, DOI 10.1016/j.transproceed.2012.09.097
  3. Klouche K, 2009, TRANSPLANTATION, V87, P889, DOI 10.1097/TP.0b013e31819a688a
  4. SADAGHDAR H, 1995, CHEST, V107, P1402, DOI 10.1378/chest.107.5.1402
  5. Candan S, 2006, TRANSPLANT P, V38, P1354, DOI 10.1016/j.transproceed.2006.02.083
  6. De Lima JJG, 2012, NEPHROL DIAL TRANSPL, V27, P2979, DOI 10.1093/ndt/gfr770
  7. Kirilov D, 2003, TRANSPLANT P, V35, P606, DOI 10.1016/S0041-1345(03)00007-1
  8. Shorr AF, 2003, CRIT CARE MED, V31, P1325, DOI 10.1097/01.CCM.0000053645.38356.A6
  9. Arulkumaran N, 2012, CLIN TRANSPLANT, V26, pE24, DOI 10.1111/j.1399-0012.2011.01520.x
  10. Badin J, 2012, TRANSPL P, V44, P2792, DOI 10.1016/j.transproceed.2012.09.027
  11. Bige N, 2014, TRANSPL INFECT DIS, V16, P588, DOI 10.1111/tid.12249
  12. Canet E, 2011, CRIT CARE, V15, DOI 10.1186/cc10091
  13. Ferreira Gustavo Fernandes, 2011, J Bras Nefrol, V33, P345, DOI 10.1590/S0101-28002011000300011